← Back to Search

Nanoscopic Meniscectomy vs Standard Meniscectomy for Meniscus Tears

N/A

Recruiting

Research Sponsored by Marshall University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 hours

Awards & highlights

Study Summary

This trial aims to compare smaller vs. larger incisions for partial meniscus tear surgery to see if the smaller incision causes less pain & faster recovery.

Who is the study for?

This trial is for individuals with confirmed meniscus tears, shown by MRI, who have enough joint space and are undergoing their first knee arthroscopy. It's not for those over 60, on workers' compensation, or needing revision surgeries.Check my eligibility

What is being tested?

The study compares two surgical methods for treating meniscus tears: a newer technique using a smaller Nanoscope and the traditional standard arthroscopic surgery. The goal is to see if the Nanoscope leads to less pain and quicker recovery.See study design

What are the potential side effects?

While specific side effects aren't listed, typical risks of meniscectomy include pain at the incision site, swelling, infection risk, blood clots in legs or lungs (rare), and potential complications from anesthesia.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Functional Outcomes Following Partial Meniscectomy: International Knee Documentation Committee Score

Functional Outcomes following partial meniscectomy: Knee Injury and Osteoarthritis Score

Secondary outcome measures

Narcotic Medication Use

Pain: Visual Analog Pain Score

Return to work

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Nanoscopic Partial MeniscectomyExperimental Treatment1 Intervention

This is the experimental group. patients will have a partial meniscectomy performed using the arthrex nanoscope

Group II: Standard Partial MeniscectomyActive Control1 Intervention

Patients will have a partial meniscectomy performed using standard arthroscopic equipment which is the current gold standard

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Marshall UniversityLead Sponsor

20 Previous Clinical Trials

4,062 Total Patients Enrolled

Medstar Washington Hospital CenterUNKNOWN

2 Previous Clinical Trials

3,400 Total Patients Enrolled

Arthrex, Inc.Industry Sponsor

44 Previous Clinical Trials

29,782 Total Patients Enrolled

1 Trials studying Meniscus Tears

50 Patients Enrolled for Meniscus Tears

Media Library

Nanoscopic partial meniscectomy Clinical Trial Eligibility Overview. Trial Name: NCT05617807 — N/A

Meniscus Tears Research Study Groups: Nanoscopic Partial Meniscectomy, Standard Partial Meniscectomy

Meniscus Tears Clinical Trial 2023: Nanoscopic partial meniscectomy Highlights & Side Effects. Trial Name: NCT05617807 — N/A

Nanoscopic partial meniscectomy 2023 Treatment Timeline for Medical Study. Trial Name: NCT05617807 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor still enrolling participants?

"Affirmative. The particulars hosted on clinicaltrials.gov validate that this experiment, which was launched on December 1st 2022, is actively recruiting participants. Approximately 100 individuals are required to be enlisted from a single medical centre."

Answered by AI

What is the recruitment rate for this clinical experiment?

"Affirmative. Records hosted on clinicaltrials.gov illustrate that this medical research study, which was initially shared December 1st 2022, is actively recruiting patients. The aim is to enlist 100 individuals from one healthcare center."

Answered by AI

In what ways does this research endeavor seek to accomplish its goals?

"Arthrex, Inc., the sponsor of this trial, has identified Functional Outcomes following partial meniscectomy as their primary outcome to be measured on a 6-week timeline. Secondary outcomes include Visual Analog Pain Score (VAPS) from 0 to 10 in regards to postoperative pain relief; Narcotic Medication Use for quantifying narcotic pain medication taken after nanoscopic partial meniscectomy versus arthroscopy; and Return To Work time frames after receiving partial meniscectomy treatment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy

Shane Taylor 2022. "Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05617807.